{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:22:17Z","timestamp":1763018537288,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary viral myocarditis associated with severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection is a rare diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of an unvaccinated, healthy patient with cardiogenic shock in the context of a COVID-19-associated myocarditis and therapy with simultaneous veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous left ventricular decompression therapy with an Impella. The aim of this review is to provide an overview of therapeutic options for patients with COVID-19-associated myocarditis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The majority of patients required a combination of two assist devices to achieve sufficient cardiac output until recovery of left ventricular ejection fraction. Due to the rapid onset of this fulminant cardiogenic shock immediate invasive bridging therapy in a specialized center was lifesaving.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-022-01890-4","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T03:02:42Z","timestamp":1670814162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Severe COVID-19-associated myocarditis with cardiogenic shock \u2013 management with assist devices \u2013 a case report &amp; review"],"prefix":"10.1186","volume":"22","author":[{"given":"Stephanie","family":"Noone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin N.","family":"Flinspach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Fichtlscherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sonntagbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6597-9585","authenticated-orcid":false,"given":"Florian J.","family":"Raimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"issue":"12","key":"1890_CR1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/medicina56120678","volume":"56","author":"ACC Agdamag","year":"2020","unstructured":"Agdamag ACC, Edmiston JB, Charpentier V, Chowdhury M, Fraser M, Maharaj VR, et al. Update on COVID-19 myocarditis. Medicina (Kaunas). 2020;56(12):678. https:\/\/doi.org\/10.3390\/medicina56120678.","journal-title":"Medicina (Kaunas)"},{"issue":"10","key":"1890_CR2","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1001\/jamacardio.2021.2828","volume":"6","author":"HW Kim","year":"2021","unstructured":"Kim HW, Jenista ER, Wendell DC, Azevedo CF, Campbell MJ, Darty SN, et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021;6(10):1196\u2013201. https:\/\/doi.org\/10.1001\/jamacardio.2021.2828.","journal-title":"JAMA Cardiol"},{"issue":"4","key":"1890_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.2021.24110","volume":"327","author":"ME Oster","year":"2022","unstructured":"Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to august 2021. JAMA. 2022;327(4):331\u201340. https:\/\/doi.org\/10.1001\/jama.2021.24110.","journal-title":"JAMA"},{"issue":"3","key":"1890_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.pcad.2020.03.001","volume":"63","author":"G Lippi","year":"2020","unstructured":"Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63(3):390\u20131. https:\/\/doi.org\/10.1016\/j.pcad.2020.03.001.","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"1890_CR5","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1053\/j.jvca.2020.06.013","volume":"35","author":"F Guarracino","year":"2021","unstructured":"Guarracino F, Vetrugno L, Forfori F, Corradi F, Orso D, Bertini P, et al. Lung, heart, vascular, and diaphragm ultrasound examination of COVID-19 patients: a comprehensive approach. J Cardiothorac Vasc Anesth. 2021;35(6):1866\u201374. https:\/\/doi.org\/10.1053\/j.jvca.2020.06.013.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"1890_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cardfail.2021.08.013","volume":"28","author":"AS Bhatt","year":"2022","unstructured":"Bhatt AS, Adler ED, Albert NM, Anyanwu A, Bhadelia N, Cooper LT, et al. Coronavirus Disease-2019 and heart failure: a scientific statement from the Heart Failure Society of America. J Card Fail. 2022;28(1):93\u2013112. https:\/\/doi.org\/10.1016\/j.cardfail.2021.08.013.","journal-title":"J Card Fail"},{"issue":"5","key":"1890_CR7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11739-021-02635-w","volume":"16","author":"D Mele","year":"2021","unstructured":"Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med. 2021;16(5):1123\u20139.","journal-title":"Intern Emerg Med"},{"key":"1890_CR8","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1053\/j.jvca.2022.01.049","volume":"36","author":"MW Haroun","year":"2022","unstructured":"Haroun MW, Patel SR, Sims D, Jorde UP, Goldstein DJ, Saeed O. Characteristics and outcomes of COVID-19 patients supported by Venoarterial or Veno-arterial-venous extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2022;36:2935\u201341.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"7","key":"1890_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/jamacardio.2020.1105","volume":"5","author":"RO Bonow","year":"2020","unstructured":"Bonow RO, Fonarow GC, O\u2019Gara PT, Yancy CW. Association of Coronavirus Disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"1890_CR10","first-page":"215","volume":"58","author":"S Venkataraman","year":"2022","unstructured":"Venkataraman S, Bhardwaj A, Belford PM, Morris BN, Zhao DX, Vallabhajosyula S. Veno-arterial extracorporeal membrane oxygenation in patients with fulminant myocarditis: a review of contemporary literature. Med. 2022;58(2):215.","journal-title":"Med"},{"issue":"1","key":"1890_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s15010-021-01645-2","volume":"50","author":"JJ Malin","year":"2022","unstructured":"Malin JJ, Spinner CD, Janssens U, Welte T, Weber-Carstens S, Sch\u00e4lte G, et al. Key summary of German national treatment guidance for hospitalized COVID-19 patients. Infection. 2022;50(1):93\u2013106. https:\/\/doi.org\/10.1007\/s15010-021-01645-2.","journal-title":"Infection"},{"issue":"9","key":"1890_CR12","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.hrthm.2020.05.001","volume":"17","author":"B Siripanthong","year":"2020","unstructured":"Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, et al. Recognizing COVID-19\u2013related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463\u201371.","journal-title":"Heart Rhythm"},{"issue":"5","key":"1890_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ejhf.1828","volume":"22","author":"G Tavazzi","year":"2020","unstructured":"Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911\u20135. https:\/\/doi.org\/10.1002\/ejhf.1828.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"1890_CR14","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.jcmg.2020.05.003","volume":"13","author":"J Salamanca","year":"2020","unstructured":"Salamanca J, D\u00edez-Villanueva P, Mart\u00ednez P, Cecconi A, Gonz\u00e1lez de Marcos B, Reyes G, et al. COVID-19 \u201cfulminant myocarditis\u201d successfully treated with temporary mechanical circulatory support. Cardio. Imag. 2020;13(11):2457\u20139.","journal-title":"Cardio. Imag"},{"issue":"7","key":"1890_CR15","volume":"12","author":"I Richard","year":"2020","unstructured":"Richard I, Robinson B, Dawson A, Aya A, Ali R. An atypical presentation of fulminant myocarditis secondary to COVID-19 infection. Cureus. 2020;12(7):e9179.","journal-title":"Cureus"},{"issue":"6","key":"1890_CR16","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1002\/ehf2.12958","volume":"7","author":"W Jacobs","year":"2020","unstructured":"Jacobs W, Lammens M, Kerckhofs A, Voets E, Van San E, Van Coillie S, et al. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature. ESC Heart Fail. 2020;7(6):3772\u201381.","journal-title":"ESC Heart Fail"},{"issue":"19","key":"1890_CR17","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1161\/CIRCULATIONAHA.120.050097","volume":"142","author":"CL Albert","year":"2020","unstructured":"Albert CL, Carmona-Rubio AE, Weiss AJ, Procop GG, Starling RC, Rodriguez ER. The enemy within: sudden-onset reversible cardiogenic shock with biopsy-proven cardiac myocyte infection by severe acute respiratory syndrome coronavirus 2. Circ. 2020;142(19):1865\u201370.","journal-title":"Circ"},{"issue":"2","key":"1890_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00414-020-02500-z","volume":"135","author":"G Gauchotte","year":"2021","unstructured":"Gauchotte G, Venard V, Segondy M, Cadoz C, Esposito-Fava A, Barraud D, et al. SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study. Int J Legal Med. 2021;135(2):577\u201381.","journal-title":"Int J Legal Med"},{"key":"1890_CR19","doi-asserted-by":"crossref","unstructured":"Othenin-Girard A, Regamey J, Lamoth F, Horisberger A, Glampedakis E, Epiney J-B, et al. Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult. Swiss Med Wkly. 2020;45.","DOI":"10.4414\/smw.2020.20387"},{"key":"1890_CR20","doi-asserted-by":"crossref","unstructured":"Verma AK, Olagoke O, Moreno JD, Rezaee N, Ma P, Liu J, et al. SARS-CoV-2\u2013associated myocarditis: a case of direct myocardial injury. Circ. Heart Fail. 2022;15.","DOI":"10.1161\/CIRCHEARTFAILURE.120.008273"},{"issue":"5","key":"1890_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s15010-020-01424-5","volume":"48","author":"J-H Zeng","year":"2020","unstructured":"Zeng J-H, Liu Y-X, Yuan J, Wang F-X, Wu W-B, Li J-X, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infect. 2020;48(5):773\u20137.","journal-title":"Infect"},{"key":"1890_CR22","doi-asserted-by":"crossref","unstructured":"Papageorgiou J-M, Almroth H, T\u00f6rnudd M, van der Wal H, Varelogianni G, Lawesson SS. Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support\u2013a case report. Eur Heart J-Case Rep. 2021;5.","DOI":"10.1093\/ehjcr\/ytaa523"},{"issue":"5","key":"1890_CR23","first-page":"583","volume":"79","author":"K Marcinkiewicz","year":"2021","unstructured":"Marcinkiewicz K, Petryka-Mazurkiewicz J, Nowicki MM, Kuriata J, Dzieli\u0144ska Z, Demkow M, et al. Acute heart failure in the course of fulminant myocarditis requiring mechanical circulatory support in a healthy young patient after coronavirus disease 2019. Kardio Pols (Pol Heart J). 2021;79(5):583\u20134.","journal-title":"Kardio Pols (Pol Heart J)"},{"issue":"1","key":"1890_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/01.ccm.0000806772.84443.86","volume":"50","author":"J Kim","year":"2022","unstructured":"Kim J, Ganguli S, Yamane D, Pocock E, Mazhari R, Hawkins K. 112: COVID-19-associated myocarditis treated with ECPELLA and glucocorticoid therapy: a CASE series. Crit Care Med. 2022;50(1):39.","journal-title":"Crit Care Med"},{"issue":"3","key":"1890_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","volume":"18","author":"C Tsch\u00f6pe","year":"2021","unstructured":"Tsch\u00f6pe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18(3):169\u201393. https:\/\/doi.org\/10.1038\/s41569-020-00435-x.","journal-title":"Nat Rev Cardiol"},{"key":"1890_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2021.107361","volume":"54","author":"SE Fox","year":"2021","unstructured":"Fox SE, Falgout L, Vander Heide RS. COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism. Cardiovasc Pathol. 2021;54:107361.","journal-title":"Cardiovasc Pathol"},{"issue":"6","key":"1890_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.recesp.2020.04.001","volume":"73","author":"\u00c1 Irabien-Ortiz","year":"2020","unstructured":"Irabien-Ortiz \u00c1, Carreras-Mora J, Sionis A, P\u00e0mies J, Montiel J, Tauron M. Fulminant myocarditis due to COVID-19. Rev Esp de Cardiol (English Edition). 2020;73(6):503\u20134.","journal-title":"Rev Esp de Cardiol (English Edition)"},{"key":"1890_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2020.107300","volume":"50","author":"MK Halushka","year":"2021","unstructured":"Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021;50:107300.","journal-title":"Cardiovasc Pathol"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01890-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01890-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T07:03:51Z","timestamp":1671087831000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01890-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1890"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01890-4","relation":{},"ISSN":["1471-2253"],"issn-type":[{"type":"electronic","value":"1471-2253"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This investigation was approved by the local ethical review board (No. #20\u2013643) of the University Frankfurt. Written consent from the patient, in accordance the guidelines of the Declaration of Helsinki, was obtained before the case report was drafted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient prior to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ANF received speaker fees from P.J. Dahlhausen & Co. GmbH, Colone, Germany and received the Sedana Medical Research Grant 2020. FJR received speaker fees from Helios Germany, university hospital W\u00fcrzburg and Keller Medical GmbH. FJR received financial support by HemoSonics LLC, pharma-consult Petersohn and Boehringer Ingelheim. KZ has received honoraria for participation in advisory board meetings for Haemonetics and Vifor and received speaker fees from CSL Behring and GE Healthcare. He is the Principal Investigator of the EU-Horizon 2020 project ENVISION (Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision-making in Intensive Care Units) and Horizon Europe 2021 project COVend (Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19). SN, SF and MS stated that they had no interests which might be perceived as posing a conflict or bias.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"385"}}